한국어
English
日本語
中文(简体)
Rapamune 1 mg Tablet (Sirolimus)
6.6mg
Prescription medication
Pfizer Korea Co., Ltd.
Sirolimus suspension is an immunosuppressant that prevents transplant rejection.
MFDS ingredient code M259798
Sirolimus suspension is a component belonging to the class of immunosuppressants, primarily used to suppress immune responses in organ transplant patients to prevent rejection of the transplanted organ. This component regulates excessive activation of the immune system through nonspecific immunosuppressive actions.
Sirolimus inhibits the proliferation and function of immune cells by blocking the activity of a specific protein complex called mTOR within the immune cells. This reduces the response of the immune system attacking the transplanted organ, thereby preventing graft rejection.
Approved uses differ by product. Check each product's information for its actual use.
Unlike other immunosuppressants, sirolimus acts by targeting the mTOR pathway. Hence, it has immunosuppressive effects along with influencing cell growth regulation, which may provide antitumor effects in certain situations.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.
